How much is Trace Neuroscience worth in 2026?

Trace Neuroscience has a current valuation of N/A based on their Early Stage VC (Series A) round and secondary market data.

How much funding has Trace Neuroscience raised?

Trace Neuroscience has raised N/A in total funding across 1 funding rounds.

Trace Neuroscience

Laboratory Services (Healthcare)

Trace Neuroscience valuation and funding history | Last updated: November 12, 2024 | 1 funding rounds

Current Valuation

N/A

As of November 12, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A)

$101.0M

Last Funding

Nov 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 12, 2024	Early Stage VC (Series A)	$101.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Trace Neuroscience is currently valued at N/A as of November 12, 2024.

Track Trace Neuroscience Valuation Updates

Get notified when Trace Neuroscience raises new funding or valuation changes

Explore More Data

Detailed analysis for Trace Neuroscience

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Trace Neuroscience's valuation history, funding rounds, and growth metrics.

No credit card required

What is Trace Neuroscience Worth in 2026?

Trace Neuroscience is a leading private company in the Laboratory Services (Healthcare) sector. Track Trace Neuroscience's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Trace Neuroscience Valuation is Determined

Private company valuations like Trace Neuroscience's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.